AZILECT Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2018
Price : $35 *
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Takeda
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.
- 02 Nov 2018 New trial record